2 July 2019
Gosse Adema, theme Cancer development and immune defense, RIMLS
Approved budget: € 580,756
Research project: Metastases-directed therapy for PET detected oligo-recurrent prostate cancer with and without short course androgen deprivation therapy
Robert Jan Smeenk / Fred Verzijlbergen, theme Urological cancers, RIHS
Approved budget: € 899,591
Research project: Dissecting the role of aberrant E-cadherin signaling in the initiation and progression of diffuse-type gastric cancer.
Chella van der Post, theme Tumors of the digestive tract, RIMLS
Approved budget: € 653,075
Research project: (Cost) Effectiveness of Blended and UnguideD DeliverY of Mindfulness‐based Cognitive Therapy versus Care as Usual for distressed cancer patients: BUDDY project
Anne Speckens, theme Stress related disorders, DCMN
Approved budget: € 494,505
Research project: Identification of genetic cancer predisposition through tumour genome mutational profiling
Richarda de Voer, theme Tumors of the digestive tract, RIMLS
Approved budget: € 566,411
Research project: Induction of neo-antigen specific T cells by specialised cross-presenting dendritic cells in epithelial ovarian cancer patients
Jolanda de Vries, theme Cancer development and immune defense, RIMLS
Approved budget: € 657,575
Erik Aarntzen, theme Tumors of the digestive tract, RIMLS
Approved budget: € 365,732
Research project: The phospho proteome, key to derailed kinases in intestinal tumors and customized therapy
Henk Verheul, theme Tumors of the digestive tract
Approved budget: € 1,091,077
Go to the Dutch Cancer Society website (KWF).
The Dutch Cancer Society (KWF) has awarded 25.5 million euros to 50 new research projects in 16 different institutes. 8 grants are awarded to Radboudumc researchers. We congratulate our researchers with this funding and wish them success with their great work.
Research projects:
Research project: Immunotherapy meets Radiotherapy: understanding cGAS to define immunogenic vs non‐immunogenic radiation conditionsGosse Adema, theme Cancer development and immune defense, RIMLS
Approved budget: € 580,756
Research project: Metastases-directed therapy for PET detected oligo-recurrent prostate cancer with and without short course androgen deprivation therapy
Robert Jan Smeenk / Fred Verzijlbergen, theme Urological cancers, RIHS
Approved budget: € 899,591
Research project: Dissecting the role of aberrant E-cadherin signaling in the initiation and progression of diffuse-type gastric cancer.
Chella van der Post, theme Tumors of the digestive tract, RIMLS
Approved budget: € 653,075
Research project: (Cost) Effectiveness of Blended and UnguideD DeliverY of Mindfulness‐based Cognitive Therapy versus Care as Usual for distressed cancer patients: BUDDY project
Anne Speckens, theme Stress related disorders, DCMN
Approved budget: € 494,505
Research project: Identification of genetic cancer predisposition through tumour genome mutational profiling
Richarda de Voer, theme Tumors of the digestive tract, RIMLS
Approved budget: € 566,411
Research project: Induction of neo-antigen specific T cells by specialised cross-presenting dendritic cells in epithelial ovarian cancer patients
Jolanda de Vries, theme Cancer development and immune defense, RIMLS
Approved budget: € 657,575
Young Investigator grant:
Research project: Imaging tumor infiltrating CD8+ T‐cells in non‐small cell lung cancer patientsErik Aarntzen, theme Tumors of the digestive tract, RIMLS
Approved budget: € 365,732
Consortium grant
Research project: The phospho proteome, key to derailed kinases in intestinal tumors and customized therapyHenk Verheul, theme Tumors of the digestive tract
Approved budget: € 1,091,077
Go to the Dutch Cancer Society website (KWF).
Related news items
![](https://www.radboudumc.nl/getmedia/a0d73d03-4f09-454b-914b-ef993072ddbc/kwf-logo-EN.aspx?width=369&height=221&ext=.png&type=BlockColumn1Zoom1)
KWF Roadshow 11 November 2019
10 October 2019 In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field. read more![](https://www.radboudumc.nl/getmedia/e4157bb9-6a5e-432f-9afa-5cf6304fd5ea/Logo-Dutch-Cancer-society.aspx?width=800&height=600&ext=.png&type=BlockColumn1Zoom1)
Internal KWF review procedure 2020
13 June 2019 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more![](https://www.radboudumc.nl/getmedia/e4157bb9-6a5e-432f-9afa-5cf6304fd5ea/Logo-Dutch-Cancer-society.aspx?width=800&height=600&ext=.png&type=BlockColumn1Zoom1)
Internal KWF review procedure 2019
4 April 2019 In agreement with the existing policy the research board and Radboudumc Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more![](https://www.radboudumc.nl/getmedia/e4157bb9-6a5e-432f-9afa-5cf6304fd5ea/Logo-Dutch-Cancer-society.aspx?width=800&height=600&ext=.png&type=BlockColumn1Zoom1)
Internal KWF review procedure 2019
19 December 2018 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more![](https://www.radboudumc.nl/getmedia/19dd369d-0aeb-4b5a-84a4-3f0e1f48cc64/BIJGESNEDEN_logo_kwf.aspx?width=500&height=300&ext=.jpg&type=BlockColumn1Zoom1)
Internal KWF review procedure December 2018
13 September 2018 First deadline is approaching. 24 October 2018 is the deadline for the registration of new applications. read more![](https://www.radboudumc.nl/getmedia/19dd369d-0aeb-4b5a-84a4-3f0e1f48cc64/BIJGESNEDEN_logo_kwf.aspx?width=500&height=300&ext=.jpg&type=BlockColumn1Zoom1)